India | ABSCH-IRCC-IN-257895 | Internationally Recognized Certificates of Compliance | Access and Benefit-Sharing Clearing-House

Loading...
  |  

Internationally Recognized Certificates of Compliance (IRCC)

See amendment history for more information.

last updated: 16 Nov 2021
General information
India Party to the NP Nagoya Protocol Signatory Entry into force: 12 Oct 2014
ABSCH-IRCC-IN-257895-1
- Competent National Authority: ABSCH-CNA-IN-202013-2 | ABSCH-CNA-IN-202013-2
Competent National Authority
National Biodiversity Authority ()
5th Floor, TICEL Biopark, CSIR Road, Taramani
Chennai, Tamilnadu
600 113, India
Phone: +91 44 2254 2777,
Fax: +91 44 2254 1200,
Details of the permit or its equivalent
India/NBA/Appl/9/INBA3202102713
Application in Form-III for seeking approval for the invention on “ Method of Developing An Antigen-Specific Library of Novel Format Stable Single Chain Nanobody ” for obtaining IP rights in India. 
Indian Patent Application No.- 922/KOL/2015
04 Oct 2021
Prior Informed Consent (PIC) Information
Yes
- Competent National Authority: ABSCH-CNA-IN-202013-2 | ABSCH-CNA-IN-202013-2
Competent National Authority
National Biodiversity Authority ()
5th Floor, TICEL Biopark, CSIR Road, Taramani
Chennai, Tamilnadu
600 113, India
Phone: +91 44 2254 2777,
Fax: +91 44 2254 1200,
Confidential information
- Person: Dr. Ena Ray Benerjee | ABSCH-CON-IN-257859-1
Person
Dr. Ena Ray Benerjee
Flat 4G, Sudrishti Apartment, 153 NSC Bose Road,
Kolkata, West Bengal
700040, India
Phone: +91-9163739975,
Fax:
Website:
- Person: Dr. Pramathadhip Paul | ABSCH-CON-IN-257860-1
Person
Dr. Pramathadhip Paul
C/o Late Dr. Prabhat Kumar Paul, Nayabasti, Mission Road, P.O & Dist.
Jalpaiguri, West Bengal
735101,
Phone: +91-9475248606,
Fax:
Website:
Confidential information
Mutually Agreed Terms (MAT) Information
Yes
1. The user shall notify NBA within 60 days from the date of grant of IPR and also assignment or license of the IPR if any, to any person. 
2. If the user himself commercializes the process/product/innovation, the monetary sharing shall be 0.2% on the annual gross ex-factory sale minus government taxes. 
3. The user shall inform NBA about any commercialization made on the IP Rights.
4. The user shall submit annual report to NBA as per the terms and conditions agreed upon. 
Subject-matter or genetic resource(s)
For obtaining IP Rights on the invention titled “ Method of Developing An Antigen-Specific Library of Novel Format Stable Single Chain Nanobody " in India.
Bioresource:
Camelus dromedarius - Arabian Camel - Blood
Confidential information


Information on the utilization of the genetic resource(s)
  • Commercial
1. If the user assigns/licenses the process/product/innovation to a third party for commercialization, the user shall pay to NBA 3.0% of the fee received (in any form including the license / assignee fee) and 2.0% of the royalty amount received annually from the assignee/licensee. 
                                                                                         
2. In case the user assigns or transfers the IPR in whole or in part to any person, whether voluntarily or involuntarily, the user undertakes to attach this agreement as an appendix to the assignment instrument which shall be binding upon such person. 
Additional Information
Amendment history
Unique identifier Status
ABSCH-IRCC-IN-257895-1
REVOKED OLD VERSION PUBLISHED DELETED
Records referencing this document Show in search
Record type Field Record(s)